Notice Number: NOT-AI-07-020

Key Dates
Release Date: January 19, 2007

Issued by
National Institutes of Allergy and Infectious Diseases (NIAID), (http://www.niaid.nih.gov)

Description

The National Institute of Allergy and Infectious Diseases intends to issue two funding opportunities to support studies of B cell immunology related to mechanisms by which broadly protective neutralizing anti-HIV-1 antibodies can be induced and maintained: (1)  the U01 Cooperative Agreement grant program will support basic immunology research on B cell and antibody regulation, and (2) the R21 Exploratory/Development grant program will support basic immunology research on B cell and antibody regulation.  The two RFAs are expected to be published in March 2007.  These programs are intended to create new collaborative research enterprises focused on a key parameter for HIV-1 vaccine development: defining the basic immune mechanisms by which effective and robust neutralizing antibodies can be elicited in uninfected individuals to protect against a broad range of HIV-1 strains. New basic research in this area is important to the development of preventive vaccines for HIV-1. 

Inquiries

Inquiries regarding this notice may be directed to:

Helen Quill, Ph.D
Basic Immunology Branch
Division of Allergy, Immunology and Transplantation, NIAID, NIH, DHHS
6610 Rockledge Drive, Room 3013, MSC 6601
Bethesda, MD  20892-7612 (Express mail:  Use Zip Code 20817-7612)
Phone 301-496-7551
Fax 301-480-2381
Email:  hquill@niaid.nih.gov 

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.